Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Feb 27, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tenaya Therapeutics, Inc.
| 35K |
—
|
—
| +57.61% | 95.75K |
Feb 23
| |||||||
Tenaya Therapeutics, Inc.
| -5.20K |
$5.86 | -$30,477.86 | -7.89% | 60.76K |
Feb 16
| |||||||
Tenaya Therapeutics, Inc.
| -4.45K |
$3.81 | -$16,962.12 | -6.45% | 64.54K |
Aug 16
| |||||||
Nkarta, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 7
| |||||||
Tenaya Therapeutics, Inc.
| 65K |
—
|
—
| +3,250.00% | 67K |
Feb 15
| |||||||
Nkarta, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 8
| |||||||
Eliem Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 19
| |||||||
Tenaya Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 15
| |||||||
Eliem Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Tenaya Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Nkarta, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 13
| |||||||
Adverum Biotechnologies, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 16
| |||||||
Adverum Biotechnologies, Inc.
| -12.53K |
$14.10 | -$176,717.74 | -11.34% | 97.95K |
Feb 9
| |||||||
Nkarta, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jul 9
| |||||||
Nkarta, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Adverum Biotechnologies, Inc.
| -13.17K |
$24.68 | -$325,060.28 | -10.65% | 110.49K |
Jun 16
| |||||||
Adverum Biotechnologies, Inc.
|
0
|
$11.73 | -$331,600.00 |
—
| 123.66K | +1 |
May 6
|
Scheduled
| |||||
Adverum Biotechnologies, Inc.
| -10.98K |
$10.24 | -$112,486.40 | -7.31% | 139.24K | +1 |
Feb 9
| ||||||
Adverum Biotechnologies, Inc.
| -15.10K |
$6.81 | -$317,889.71 | -10.90% | 123.43K | +1 |
Mar 20
|
Scheduled
| |||||
Adverum Biotechnologies, Inc.
| -474.00 |
$10.02 | -$4,749.24 | -0.34% | 138.53K | +1 |
Mar 17
|
Scheduled
| |||||
Adverum Biotechnologies, Inc.
|
0
|
—
|
—
|
—
|
0
| +1 |
Feb 20
| ||||||
Adverum Biotechnologies, Inc.
| -11.21K |
$10.24 | -$114,841.60 | -7.47% | 139K | +1 |
Feb 9
| ||||||
Adverum Biotechnologies, Inc.
| -40.00K |
$10.72 | -$428,800.00 | -21.03% | 150.22K | +1 |
Dec 23
|
Scheduled
| |||||
Adverum Biotechnologies, Inc.
| -78.28K |
$6.90 | -$632,917.37 | -18.17% | 352.62K | +1 |
Jun 15 - Jun 15
| ||||||
Adverum Biotechnologies, Inc.
| -40.00K |
$10.72 | -$428,800.00 | -14.90% | 228.5K | +1 |
Dec 23
|
Scheduled
| |||||
Adverum Biotechnologies, Inc.
|
0
|
—
|
—
|
—
|
0
| +1 |
Feb 14
| ||||||
Adverum Biotechnologies, Inc.
|
0
|
—
|
—
|
—
|
0
| +1 |
Oct 18
| ||||||
Adverum Biotechnologies, Inc.
| 88.5K |
—
|
—
| +49.16% | 268.5K | +2 |
Jun 15
| ||||||
Adverum Biotechnologies, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 15
| |||||||
Adverum Biotechnologies, Inc.
| 80K |
—
|
—
| +80.00% | 180K |
Feb 9
| |||||||
Adverum Biotechnologies, Inc.
| 100K |
—
|
—
|
∞
| 100K |
Jun 15
| |||||||
Adverum Biotechnologies, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Diadexus, Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 20
| |||||||
Diadexus, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Transcept Pharmaceuticals Inc
| 4.16K |
$21.59 | $89,827.67 |
∞
| 4.16K | +1 |
Oct 30
| ||||||
Transcept Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
| +1 | |||||||
Transcept Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
| +1 |
Jul 15
| ||||||
Transcept Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
| +1 |
Jan 7
| ||||||
Transcept Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
| +1 |
Jun 25
| ||||||
Transcept Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
| +1 | |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.